Paediatrics Search
Paediatrics Paediatrics
neonatal%20jaundice
NEONATAL JAUNDICE
Jaundice that appears in a newborn <24 hour old is most likely nonphysiologic and needs further evaluation.
Jaundice typically presents on the 2nd-3rd day of life. It is usually first seen on the face and forehead then progresses caudally to the trunk and extremities.
Visible jaundice in the feet may be an indication to check bilirubin level.
Visual estimation of bilirubin level is often inaccurate and unreliable.
Danger signs in a newborn infant with jaundice includes changes in brainstem evoked auditory potentials, changes in muscle tone, seizures and altered cry characteristics.
The presence of any of the danger signs require prompt attention to prevent kernicterus.
Drug Information

Indication: Restoration & maintenance of circulating blood vol.

Indication: Shock, burns, hypoproteinaemia, hyperbilirubinaemia, cardiopulmonary bypass procedures.

Indication: Albumin deficiency therapy. Increase oncotic pressure in case of oncotic deficiency. Iso-oncotic vol replaceme...

Indication: Hypovolemic shock, hyperbilirubinemia, acute nephrosis, cardiopulmonary bypass procedures.

Indication: Short-term treatment of insomnia; relieve anxiety, tension & apprehension; long-term anticonvulsant therap...

Indication: Emergency treatment of hypovolemic shock, burn therapy, hypoproteinemia w/ or w/o edema, adult resp distress s...

Indication: Restoration & maintenance of circulating blood vol where vol deficiency has been demonstrated.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Every-2-month cabotegravir + rilpivirine feasible for HIV treatment
Pearl Toh, 4 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Why are there fewer COVID-19 cases in children?
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
Sustained lopinavir use may improve condition of COVID-19 patients
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
13 ways to fight COVID-19
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.